• November 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million. Abbott Animal Health is a companion animal health business focused on the veterinary surgical suite. This acquisition will strengthen Zoetis’ companion animal product portfolio and expand its diagnostics business as more pets are being treated for pain and serious illnesses, such as cancer and diabetesmore...
  • November 14, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has adopted a one-year shareholder rights plan (the “Plan”) and declared a dividend distribution of one preferred share purchase right (a “Right”) for each outstanding share of the Company’s common stock. The Plan will automatically expire on November 16, 2015, unless the Rights are earlier redeemed, exchanged or terminated. The Plan is intended to protect shareholdersmore...
  • November 13, 2014
    LONDON, UK – Nov. 13, 2014 - A consortium of academic and animal health industry partners in the UK, led by Zoetis Inc., is embarking on a pioneering 42-month project that will develop visual imaging methods and digital technologies to help producers improve the health and wellness of pig herds and enhance production efficiency.  The $3 million (USD) project, announced today, is funded by an Agri-Tech Catalyst Award from Innovate UK, the UK’s innovation agency.  The partners willmore...
  • November 5, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec. 2, in New York, N.Y. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Dr. Catherine Knupp, Executive Vice President and President, Research and Development, will represent the company and respond to questions from analysts. They are scheduled to present at 8:30 a.m. EST. Investors and other interestedmore...
  • November 4, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2014. The company reported revenue of $1.2 billion for the third quarter of 2014, an increase of 10% from the third quarter of 2013. Revenue reflected an operational2 increase of 10%, with foreign currency having no material impact on revenue growth this quarter. Net income for the third quarter of 2014 was $166 million, or $0.33 per dilutedmore...
  • October 27, 2014
    PARIS, FRANCE - October 27, 2014 – A new European research centre, comprising a collaborative network of veterinarians, scientists and technical specialists with a coordinating hub in Edinburgh, Scotland, aims to identify emerging diseases in livestock and companion animals, and enhance the ability to control them.This centre of excellence is a collaboration between the Easter Bush Research Consortium (EBRC) and global animal health company Zoetis.  This collaboration forms a part ofmore...
  • October 16, 2014
    SHANGHAI, CHINA – Oct. 15, 2014 – Zoetis Inc. and Nestlé today announced an agreement in which Zoetis will develop the educational curriculum for the Dairy Farming Institute (DFI) in Shuangcheng, Heilongjiang Province in Northeast China.Zoetis will bring to the Institute and its partner organizations veterinary medical and technical expertise. The company will leverage its veterinary and dairy producer relationships to advance the work of the Institute in helping China’s dairy farmers meet themore...
  • October 2, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) declared a fourth quarter dividend payable to holders of the company’s common stock of $0.072 per share. The dividend is to be paid on Tuesday, Dec. 2, 2014, to holders of record on Wednesday, Nov. 5, 2014. About Zoetis Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 yearsmore...
  • September 30, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) will host a webcast and conference call at 8:30 a.m. (EST) on Tuesday, November 4, 2014. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Paul Herendeen will review third quarter 2014 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at httpmore...
  • September 25, 2014
    FLORHAM PARK, NJ, Sept. 25, 2014 — Zoetis now offers a test to quickly and accurately screen for the detection of antibodies to Johne’s Disease in cattle, the company announced today.Matthew Krecic, DVM, MS, MBA, DACVIM, Senior Technical Services Manager of U.S. Diagnostics, Zoetis, said the test uses an indirect immunoenzymatic technique to detect Mycobacterium avium, subspecies paratuberculosis (M. ParaTB) antibodies in samples of cattle serum and plasma. Results are available in less thanmore...